Gossamer Bio Inc (NASDAQ:GOSS) price on Thursday, May 09,fall -1.30% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.75.
A look at the stock’s price movement, the close in the last trading session was $0.76. Turning to its 52-week performance, $1.88 and $0.45 were the 52-week high and 52-week low respectively. Overall, GOSS moved -25.42% over the past month.
Gossamer Bio Inc’s market cap currently stands at around $168.67 million.
Turning to the stock’s technical picture we see that short term indicators suggest on average that GOSS is a 100% Sell. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
GOSS’s current price about -2.99% and -31.12% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 38.44, while 7-day volatility ratio is 10.72% and 10.52% in the 30-day chart. Further, Gossamer Bio Inc (GOSS) has a beta value of 1.96, and an average true range (ATR) of 0.08.
If we refocus on Gossamer Bio Inc (NASDAQ:GOSS), historical trading data shows that trading volumes averaged 1.73 million over the past 3 months. The company’s latest data on shares outstanding shows there are 225.41 million shares.
The 16.27% of Gossamer Bio Inc’s shares are in the hands of company insiders while institutional holders own 79.73% of the company’s shares. Current price change has pushed the stock -18.29% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GOSS stock continues to rise going into the next quarter.